Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan.

Liu, Zeming; Li, Jinpeng; Huang, Jianglong; Guo, Liang; Gao, Rongfen; Luo, Kuan; Zeng, Guang; Zhang, Tingbao; Yi, Meilin; Huang, Yihui; Chen, Jincao; Yang, Yibin; Wu, Xiaohui

Aims: This study aimed to investigate the clinical courses and outcomes of diabetes mellitus patients with coronavirus disease 2019 (COVID-19) in Wuhan. Methods: This study enrolled 1,880 consecutive patients with confirmed COVID-19 in Leishenshan Hospital. We collected and analyzed their data, including demographic data, history of comorbidity, clinical symptoms, laboratory tests, chest computed tomography (CT) images, treatment options, and survival. Results: The percentages of patients with diabetes among the severe and critical COVID-19 cases were higher than those among the mild or general cases (89.2%, 10.8 vs. 0%, p = 0.001). However, patients with and without diabetes showed no difference in the follow-up period (p = 0.993). The mortality rate in patients with or without diabetes was 2.9% (n = 4) and 1.1% (n = 9), respectively (p = 0.114). Univariate and multivariate Cox regression analyses and the Kaplan-Meier curves did not show any statistically significant differences between patients with and without diabetes (all p > 0.05). Conclusions: Our study results suggested that diabetes had no effect on the prognosis of COVID-19 patients but had a negative association with their clinical courses. These results may be useful for clinicians in the management of diabetic patients with COVID-19.

WUHAN (China); COVID-19; PEOPLE with diabetes; SCIENTIFIC observation; SYMPTOMS; DIABETES

Frontiers in Endocrinology, 2020, Vol 11, p1

1664-2392

Academic Journal

10.3389/fendo.2020.00478